About
Proterris develops carbon monoxide-based therapeutic treatments targeting organ transplant complications, inflammatory diseases, and oncology, leveraging the cytoprotective and anti-inflammatory properties of CO.
Explore Proterris's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.